A citation-based method for searching scientific literature

Rita T Lawlor, Nicola Veronese, Antonio Pea, Alessia Nottegar, Lee Smith, Camilla Pilati, Jacopo Demurtas, Matteo Fassan, Liang Cheng, Claudio Luchini. BMC Cancer 2019
Times Cited: 18







List of co-cited articles
162 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra,[...]. Am J Pathol 2011
287
72

DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Jeremy D Henson, Ying Cao, Lily I Huschtscha, Andy C Chang, Amy Y M Au, Hilda A Pickett, Roger R Reddel. Nat Biotechnol 2009
268
44


Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
572
38

Alternative Lengthening of Telomeres through Two Distinct Break-Induced Replication Pathways.
Jia-Min Zhang, Tribhuwan Yadav, Jian Ouyang, Li Lan, Lee Zou. Cell Rep 2019
87
33

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
222
33

The C-Circle Assay for alternative-lengthening-of-telomeres activity.
Jeremy D Henson, Loretta M Lau, Sylvia Koch, Nancy Martin La Rotta, Rebecca A Dagg, Roger R Reddel. Methods 2017
51
33

Telomere Maintenance Mechanisms in Cancer.
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, Manuel Sobrinho-Simões, Paula Soares, João Vinagre. Genes (Basel) 2018
48
33

Break-induced telomere synthesis underlies alternative telomere maintenance.
Robert L Dilley, Priyanka Verma, Nam Woo Cho, Harrison D Winters, Anne R Wondisford, Roger A Greenberg. Nature 2016
202
27

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, David T W Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes,[...]. Nature 2012
27

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, Supawat Thongthip, Joanne Bruno, Titia de Lange, Saurav De, John H J Petrini, Patricia A Sung, Maria Jasin,[...]. PLoS Genet 2012
347
27

The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT).
Robert Lu, Julienne J O'Rourke, Alexander P Sobinoff, Joshua A M Allen, Christopher B Nelson, Christopher G Tomlinson, Michael Lee, Roger R Reddel, Andrew J Deans, Hilda A Pickett. Nat Commun 2019
49
27

Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
T R Yeager, A A Neumann, A Englezou, L I Huschtscha, J R Noble, R R Reddel. Cancer Res 1999
498
27


Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
Luca Pompili, Carlo Leonetti, Annamaria Biroccio, Erica Salvati. J Exp Clin Cancer Res 2017
18
27

A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
Jeremy D Henson, Jonathan A Hannay, Stanley W McCarthy, Janice A Royds, Thomas R Yeager, Robert A Robinson, Stephen B Wharton, David A Jellinek, Susan M Arbuckle, Jinyoung Yoo,[...]. Clin Cancer Res 2005
202
27

Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors.
Aatur D Singhi, Ta-Chiang Liu, Justin L Roncaioli, Dengfeng Cao, Herbert J Zeh, Amer H Zureikat, Allan Tsung, J Wallis Marsh, Kenneth K Lee, Melissa E Hogg,[...]. Clin Cancer Res 2017
96
27

Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.
Joo Young Kim, Jacqueline A Brosnan-Cashman, Soyeon An, Sung Joo Kim, Ki-Byung Song, Min-Sun Kim, Mi-Ju Kim, Dae Wook Hwang, Alan K Meeker, Eunsil Yu,[...]. Clin Cancer Res 2017
57
27

Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.
V Hakin-Smith, D A Jellinek, D Levy, T Carroll, M Teo, W R Timperley, M J McKay, R R Reddel, J A Royds. Lancet 2003
206
27

In perspective: An update on telomere targeting in cancer.
Eric T Sugarman, Gao Zhang, Jerry W Shay. Mol Carcinog 2019
20
22

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis.
Ayalew Tefferi, Terra L Lasho, Kebede H Begna, Mrinal M Patnaik, Darci L Zblewski, Christy M Finke, Rebecca R Laborde, Emnet Wassie, Lauren Schimek, Curtis A Hanson,[...]. N Engl J Med 2015
198
22

FANCM limits ALT activity by restricting telomeric replication stress induced by deregulated BLM and R-loops.
Bruno Silva, Richard Pentz, Ana Margarida Figueira, Rajika Arora, Yong Woo Lee, Charlotte Hodson, Harry Wischnewski, Andrew J Deans, Claus M Azzalin. Nat Commun 2019
48
22

Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma.
Yu-Jen Chen, Vicky Hakin-Smith, Mario Teo, George E Xinarianos, David A Jellinek, Thomas Carroll, David McDowell, Martin R MacFarlane, Ronald Boet, Bruce C Baguley,[...]. Cancer Res 2006
55
22

Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX.
Yang Hu, Guang Shi, Laichen Zhang, Feng Li, Yuanling Jiang, Shuai Jiang, Wenbin Ma, Yong Zhao, Zhou Songyang, Junjiu Huang. Sci Rep 2016
45
22


Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.
Jian Hu, Soyoon Sarah Hwang, Marc Liesa, Boyi Gan, Ergun Sahin, Mariela Jaskelioff, Zhihu Ding, Haoqiang Ying, Adam T Boutin, Hailei Zhang,[...]. Cell 2012
183
22


Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Gary A Ulaner, Hsuan-Ying Huang, Jesse Otero, Zhiquan Zhao, Leah Ben-Porat, Jaya M Satagopan, Richard Gorlick, Paul Meyers, John H Healey, Andrew G Huvos,[...]. Cancer Res 2003
135
22

Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis.
Lorenza Venturini, Rosita Motta, Alessandro Gronchi, MariaGrazia Daidone, Nadia Zaffaroni. BMC Cancer 2010
27
22

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
22

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
22


BLM and SLX4 play opposing roles in recombination-dependent replication at human telomeres.
Alexander P Sobinoff, Joshua Am Allen, Axel A Neumann, Sile F Yang, Monica E Walsh, Jeremy D Henson, Roger R Reddel, Hilda A Pickett. EMBO J 2017
64
16

FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres.
Xiaolei Pan, William C Drosopoulos, Louisa Sethi, Advaitha Madireddy, Carl L Schildkraut, Dong Zhang. Proc Natl Acad Sci U S A 2017
51
16

RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells.
Rajika Arora, Yongwoo Lee, Harry Wischnewski, Catherine M Brun, Tobias Schwarz, Claus M Azzalin. Nat Commun 2014
201
16


Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions.
Anthony J Cesare, Zeenia Kaul, Scott B Cohen, Christine E Napier, Hilda A Pickett, Axel A Neumann, Roger R Reddel. Nat Struct Mol Biol 2009
164
16

Alternative lengthening of telomeres in mammalian cells.
Jeremy D Henson, Axel A Neumann, Thomas R Yeager, Roger R Reddel. Oncogene 2002
461
16


G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma.
Yuxiang Wang, Jie Yang, Aaron T Wild, Wei H Wu, Rachna Shah, Carla Danussi, Gregory J Riggins, Kasthuri Kannan, Erik P Sulman, Timothy A Chan,[...]. Nat Commun 2019
52
16

ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization.
Fei Li, Zhong Deng, Ling Zhang, Caizhi Wu, Ying Jin, Inah Hwang, Olga Vladimirova, Libo Xu, Lynnie Yang, Bin Lu,[...]. EMBO J 2019
19
16

Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
631
16

Alternative lengthening of human telomeres is a conservative DNA replication process with features of break-induced replication.
Fani-Marlen Roumelioti, Sotirios K Sotiriou, Vasiliki Katsini, Maria Chiourea, Thanos D Halazonetis, Sarantis Gagos. EMBO Rep 2016
82
16



Detection of alternative lengthening of telomeres by telomere quantitative PCR.
Loretta M S Lau, Rebecca A Dagg, Jeremy D Henson, Amy Y M Au, Janice A Royds, Roger R Reddel. Nucleic Acids Res 2013
51
16

Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin.
Harikleia Episkopou, Irena Draskovic, Amandine Van Beneden, Gaëlle Tilman, Marina Mattiussi, Matthieu Gobin, Nausica Arnoult, Arturo Londoño-Vallejo, Anabelle Decottignies. Nucleic Acids Res 2014
100
16

Telomere maintenance by telomerase and by recombination can coexist in human cells.
M A Cerone, J A Londono-Vallejo, S Bacchetti. Hum Mol Genet 2001
145
16

Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Mohammad A Jafri, Shakeel A Ansari, Mohammed H Alqahtani, Jerry W Shay. Genome Med 2016
228
16

Alternative Lengthening of Telomeres: DNA Repair Pathways Converge.
Alexander P Sobinoff, Hilda A Pickett. Trends Genet 2017
73
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.